Redoxis AB
VerifiedRedoxis is a preclinical CRO with focus on inflammation and autoimmune conditions
Gothenburg Västra Götaland County (HQ)
RELATED LANDSCAPES AND LISTS
Financials
Edit| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E |
|---|---|---|---|---|---|---|---|
| Revenues | 1m | <1m | <1m | 1m | 1m | - | - |
| % growth | - | (30 %) | (14 %) | 67 % | - | - | - |
| EBITDA | <1m | <1m | <1m | <1m | <1m | - | - |
| % EBITDA margin | 30 % | 29 % | 5 % | 20 % | 20 % | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - Not yet verified | |
| €360k | Grant | ||
| N/A | Grant Not yet verified | ||
| Total Funding | $396k | ||
Recent News about Redoxis AB
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.